Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Cancer Immunology Research
|
April 26, 2014
PD-L1 expression in triple-negative breast cancer
Elizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer
Krishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Annals of Surgery
|
October 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy
Dominic J Vitello, Dhavan Shah, Amy Wells, et al.
Annals of Surgery
|
October 21, 2020
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
Akhil Chawla, Motaz Qadan, Carlos Fernandez-Del Castillo, et al.
Skeletal Radiology
|
March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location
Linkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies
Lynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Surgery
|
November 14, 2021
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy
Shimpei Maeda, Michael A Mederos, Akhil Chawla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
Derek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer
Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Cancer Immunology Research
|
April 26, 2014
PD-L1 expression in triple-negative breast cancer
Elizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer
Krishay Sridalla, Jasmine K Machhi, Dominic J Vitello, et al.
Annals of Surgery
|
October 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer in Patients Treated with Neoadjuvant Chemotherapy
Dominic J Vitello, Dhavan Shah, Amy Wells, et al.
Annals of Surgery
|
October 21, 2020
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
Akhil Chawla, Motaz Qadan, Carlos Fernandez-Del Castillo, et al.
Skeletal Radiology
|
March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location
Linkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies
Lynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Surgery
|
November 14, 2021
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy
Shimpei Maeda, Michael A Mederos, Akhil Chawla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
Derek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer
Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
Page
of 5